News & Press Releases

Mintz represented Synnovation Therapeutics LLC, a clinical-stage biotechnology company with a diverse pipeline of novel small-molecule targeted therapies in oncology and immunology, in connection with its definitive agreement with Novartis to acquire Synnovation’s wholly-owned subsidiary, Pikavation Therapeutics Inc., and its portfolio of pan mutant selective PI3Kα inhibitor programs, including its lead clinical asset SNV4818.  

Mintz advised the underwriters in connection with SAB Biotherapeutics’ $85 million public offering.

Mintz represented Sixth Street in connection with a $1.3 billion financing – alongside co-investor Blackstone Credit & Insurance – in support of the combination of Paratek Pharmaceuticals (Paratek) and Radius Health (Radius), creating a scaled, multi‑product specialty pharmaceutical company backed by B‑FLEXION Life Sciences.  

Mintz represented Swarmer, Inc (Nasdaq: SWMR), a defense technology company specializing in drone autonomy software, in its initial public offering on the Nasdaq Capital Market. 

Member Marc Axelbaum has been recognized for the second year in a row as one of Lawdragon’s 2026 “100 Leading AI & Legal Tech Advisors”  in the White Collar, Investigations, Technology category.  

Three Mintz attorneys have been ranked in Legal 500’s US City Elite guide. The ranking honors lawyers working at the top of the legal market in their cities, states, or regions across the United States.